Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Combined Pituitary Hormone Deficiencies Global Market Report 2024 Including: 1) By Inheritance: Autosomal Dominant; Autosomal Recessive; X-linked Recessive 2) By Diagnosis: Blood Tests; Imaging Tests 3) By Treatment: Hormone Replacement Therapy Medication; Levothyroxine; Corticosteroids 4) By Distribution Channel: Hospital Pharmacy ; Retail Pharmacy ; Online Pharmacy 5) By End-Users: Hospitals; Specialty Clinics; Homecare Covering: Pfizer Inc.; Merck & Co Inc.; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG
... Hospital Pharmacy ; Retail Pharmacy ; Online Pharmacy5) By End-Users: Hospitals; Specialty Clinics; HomecareCovering: Pfizer Inc.; Merck & Co Inc.; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG Combined Pituitary Hormone Deficiencies Global Market Report 2024 ... Read More
-
Digital Pharmacy Global Market Report 2024 Including: 1) By Product: Medicines And Treatments; Personal Care Products; Vitamins And Supplements 2) By Drug Type: Prescription Medicines; Over-The-Counter (OTC) Products 3) By Business Model: Captive; Franchise; Aggregator 4) By Platform: App-Based; Web-Based 5) By Application: Urban Areas; Rural Areas Covering: Walmart Inc. ; Amazon.com Inc.; MetLife Inc.; Omnicell (OMCL) Inc.; Hims & Hers Health Inc.
... App-Based; Web-Based5) By Application: Urban Areas; Rural AreasCovering: Walmart Inc. ; Amazon.com Inc.; MetLife Inc.; Omnicell (OMCL) Inc.; Hims & Hers Health Inc. Digital Pharmacy Global Market Report 2024 from The Business Research Company provides ... Read More
-
Duodenal Ulcer Treatment Global Market Report 2024 Including: 1) By Type: Antibiotics; Proton Pump Inhibitors; Antacids; Potassium-Competitive Acid Blockers; H2-Antagonist; Ulcer Protective Drugs; Surgery 2) By Application: Adult; Elderly 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb
... Online PharmacyCovering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A; Bristol-Myers Squibb Duodenal Ulcer Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Contraceptive Devices Global Market Report 2024 Including: 1) By Product Type: Male Contraceptive Devices; Female Contraceptive Devices; Female Condoms, Diaphragms And Sponges; Vaginal Rings; Intrauterine Devices; Sub-Dermal Implants 2) By Technology: Hormonal Contraceptives; Barrier Contraceptives 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO) Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Boehringer Ingelheim International GmbH.; Teva Pharmaceutical Industries Ltd.
... Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channel And Non-Governmental Organization (NGO)Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; Bayer AG; Boehringer Ingelheim International GmbH.; Teva Pharmaceutical Industries Ltd. Contraceptive Devices Global ... Read More
-
Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 Including: 1) By Type: Empagliflozin; Dapagliflozin; Canagliflozin 2) By Application: Application I; Application II; Application III; Application IV 3) By Channel: Hospital; Pharmacy Covering: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC
... Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the ... Read More
-
North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The North America epilepsy market was valued at US$ 2,577.10 million in 2022 and is ... Read More
-
Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Europe epilepsy market was valued at US$ 1,940.58 million in 2022 and is expected to ... Read More
-
Asia Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Asia Pacific epilepsy market was valued at US$ 2,200.92 million in 2022 and is ... Read More
-
Pharmacy Benefit Management in the US - Industry Market Research Report
... the US healthcare system. They help process prescription claims, negotiate rebates, develop drug formularies and review drug usage rates. Historically, PBMs have served as third-party administrators of prescription drug programs. The role of PBMs has ... Read More
-
Invasive Ductal Carcinoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy), By Type (Hormone Receptor, HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other), By Region and Competition, 2019-2029F
... Other), By Region and Competition, 2019-2029F Global Invasive Ductal Carcinoma Treatment Market was valued at USD 8.52 Billion in 2023 and is expected to reach USD 13.49 Billion by 2029 with a CAGR of 8.13% ... Read More
-
Vaccines Market by Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), Route of Administration (Parenteral and Oral), Disease Indication and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... vaccines market size was valued at $77.04 billion in 2024 and is projected to reach $91.99 billion by 2030, growing at a CAGR of 3.0% during the forecast period. Vaccines Market Overview A vaccine is ... Read More
-
Rapid Acting Insulin Market Report by Product (Lispro Insulin, Aspart Insulin, Glulisine Insulin), Indication (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2024-2032
... global rapid acting insulin market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. ... Read More
-
India Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F India generic drugs market is projected to witness a CAGR of 8.29% during the forecast period FY2025-FY2032, growing from USD ... Read More
-
Saudi Arabia Over The Counter Drugs Market By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast and Opportunities, 2019-2029F
... Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast and Opportunities, 2019-2029F Japan Sarcoma Drugs Market was valued at USD 32.25 Million in 2024 and is ... Read More
-
Hearing Aids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (BTE, Canal Hearing Aids), By Technology (Digital, Analog), By Distribution Channel (Retail Store, e-Pharmacy and Others), By Region and Competition, 2019-2029F
... Competition, 2019-2029F Global Hearing Aids Market was valued at USD 7.45 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.81% through 2029. The global hearing ... Read More
-
Japan Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD ... Read More
-
United States Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F United States generic drugs market is projected to witness a CAGR of 6.68% during the forecast period 2024-2031, growing ... Read More
-
Vietnam Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Vietnam generic drugs market is projected to witness a CAGR of 8.39% during the forecast period 2024-2031, growing from USD ... Read More
-
Emergency Department Information Systems
... reach US$2.0 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2023-2030. Computerized Physician Order Entry (CPOE) Application, one of the segments analyzed in the report, is expected to record a ... Read More
-
Online Vitamin & Supplement Sales in the US - Industry Market Research Report
... from increased e-commerce activity and rising health consciousness. An aging population also helped boost sales, as older consumers tend to spend more on vitamins and supplements than younger demographics. The COVID-19 pandemic resulted in sales ... Read More
-
Global Pharmaceuticals Wholesale and Distribution Market 2024-2028
... the pharmaceuticals wholesale and distribution market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Wearable Medical Devices Market, By Product Type (Wearable Therapeutic Medical Devices, Wearable Monitoring and Diagnostic Devices and Health and Fitness Devices), By Application (Remote Patient Monitoring, Early Disease Detection, Chronic Disease Management, Fitness and Wellness, Rehabilitation, Surgical and Clinical Applications), By End User (Hospitals and Clinics, Hospital Pharmacies, Online Channels, Hypermarkets , Homecare Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Rehabilitation, Surgical and Clinical Applications), By End User (Hospitals and Clinics, Hospital Pharmacies, Online Channels, Hypermarkets , Homecare Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global wearable ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Global gastroenterology market growth is ... Read More
-
Global Robotic Pharmacy Prescription Dispensing Systems Market 2024-2028
... The report on the robotic pharmacy prescription dispensing systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Kenya Pharmaceutical Market, By Drug Type (Generic Drugs, Branded Drugs), By Product Type (Prescription Drugs, Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2019-2029F
... Region, Competition, Forecast & Opportunities, 2019-2029F Kenya Pharmaceutical Market was valued at USD 721.23 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.10% through 2029. ... Read More